Veradigm Inc. – OTC:MDRX

Financial Health
0
1
2
3
4
5
6
7
8
9

Veradigm stock price monthly change

-4.06%
month

Veradigm stock price quarterly change

-4.06%
quarter

Veradigm stock price yearly change

-9.22%
year

Veradigm key metrics

Market Cap
1.02B
Enterprise value
1.13B
P/E
14.99
EV/Sales
1.34
EV/EBITDA
6.91
Price/Sales
1.67
Price/Book
1.19
PEG ratio
-0.19
EPS
N/A
Revenue
N/A
EBITDA
N/A
Income
N/A
Revenue Q/Q
-100%
Revenue Y/Y
-100%
Profit margin
7.24%
Oper. margin
8.07%
Gross margin
48.42%
EBIT margin
8.07%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Veradigm stock price history

Veradigm stock forecast

Veradigm financial statements

Veradigm Inc. (OTC:MDRX): Profit margin
Dec 2022 0 0
Mar 2023 0 0
Jun 2023 0 0
Sep 2023 0 0
Veradigm Inc. (OTC:MDRX): Analyst Estimates
2025 676.68M 43.3M 6.4%
2026 710.4M 59.8M 8.42%
  • Analysts Price target

  • Financials & Ratios estimates

Veradigm Inc. (OTC:MDRX): Earnings per share (EPS)
2022-11-03 0.19 0.23
2023-03-01 0.23 0.72
Veradigm Inc. (OTC:MDRX): Debt to assets
Sep 2022 1690700000 513.7M 30.38%
Mar 2023 0 0
Jun 2023 0 0
Sep 2023 0 0
Veradigm Inc. (OTC:MDRX): Cash Flow
Dec 2022 0 0 0
Mar 2023 0 0 0
Jun 2023 0 0 0
Sep 2023 0 0 0

Veradigm alternative data

Veradigm Inc. (OTC:MDRX): Employee count
Aug 2023 8,000
Sep 2023 8,000
Oct 2023 8,000
Nov 2023 8,000
Dec 2023 8,000
Jan 2024 8,000
Feb 2024 8,000
Mar 2024 8,000
Apr 2024 8,000
May 2024 8,000
Jun 2024 8,000
Jul 2024 8,000

Veradigm other data

89.78% +6.31%
of MDRX is owned by hedge funds
106.57M -9.19M
shares is hold by hedge funds

Veradigm Inc. (OTC:MDRX): Insider trades (number of shares)
Period Buy Sel
Feb 2024 6225000 0
Mar 2024 3997875 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
STONEHILL CAPITAL MANAGEMENT LLC 10 percent owner
Common Stock, par value $0.01 per share 2,398,725 $6 $14,392,350
Purchase
STONEHILL CAPITAL MANAGEMENT LLC 10 percent owner
Common Stock, par value $0.01 per share 1,599,150 $6 $9,594,900
Purchase
STONEHILL CAPITAL MANAGEMENT LLC 10 percent owner
Common Stock, par value $0.01 per share 278,250 $6.09 $1,694,543
Purchase
STONEHILL CAPITAL MANAGEMENT LLC 10 percent owner
Common Stock, par value $0.01 per share 246,750 $6.09 $1,502,708
Purchase
STONEHILL CAPITAL MANAGEMENT LLC 10 percent owner
Common Stock, par value $0.01 per share 3,021,000 $6.81 $20,573,010
Purchase
STONEHILL CAPITAL MANAGEMENT LLC 10 percent owner
Common Stock, par value $0.01 per share 2,679,000 $6.81 $18,243,990
Sale
POULTON RICHARD J. director, officer: CEO
Common Stock 10,000 $17.33 $173,300
Sale
POULTON RICHARD J. director, officer: CEO
Common Stock 10,000 $17.38 $173,840
Sale
VAKHARIA TEJAL officer: SVP Gene.. Common Stock 8,642 $18.42 $159,194
Sale
STEVENS DAVID B director
Common Stock 43,134 $18.47 $796,814
Monday, 9 December 2024
businesswire.com
Thursday, 21 November 2024
businesswire.com
Tuesday, 19 November 2024
businesswire.com
Tuesday, 12 November 2024
seekingalpha.com
Thursday, 10 October 2024
businesswire.com
Thursday, 26 September 2024
businesswire.com
Thursday, 29 August 2024
businesswire.com
Monday, 12 August 2024
globenewswire.com
Wednesday, 12 June 2024
businesswire.com
Monday, 10 June 2024
globenewswire.com
Friday, 7 June 2024
businesswire.com
Monday, 3 June 2024
globenewswire.com
Thursday, 30 May 2024
businesswire.com
Tuesday, 28 May 2024
businesswire.com
businesswire.com
Thursday, 16 May 2024
businesswire.com
Wednesday, 15 May 2024
businesswire.com
Tuesday, 14 May 2024
businesswire.com
Tuesday, 30 April 2024
businesswire.com
Tuesday, 9 April 2024
businesswire.com
Wednesday, 3 April 2024
businesswire.com
Tuesday, 26 March 2024
prnewswire.com
Thursday, 14 March 2024
businesswire.com
Wednesday, 13 March 2024
businesswire.com
Friday, 1 March 2024
Zacks Investment Research
Friday, 5 January 2024
Zacks Investment Research
Thursday, 4 January 2024
Business Wire
Friday, 10 November 2023
Zacks Investment Research
Monday, 9 October 2023
Zacks Investment Research
Wednesday, 4 October 2023
Zacks Investment Research
  • When is Veradigm's next earnings date?

    Unfortunately, Veradigm's (MDRX) next earnings date is currently unknown.

  • Does Veradigm pay dividends?

    No, Veradigm does not pay dividends.

  • How much money does Veradigm make?

    Veradigm has a market capitalization of 1.02B.

  • What is Veradigm's stock symbol?

    Veradigm Inc. is traded on the OTC under the ticker symbol "MDRX".

  • What is Veradigm's primary industry?

    Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.

  • How do i buy shares of Veradigm?

    Shares of Veradigm can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Veradigm's key executives?

    Veradigm's management team includes the following people:

    • Mr. Paul M. Black Chief Executive Officer & Director(age: 67, pay: $2,770,000)
    • Mr. Richard J. Poulton Pres & Chief Financial Officer(age: 60, pay: $1,920,000)
    • Ms. Tejal Vakharia Senior Vice President and Gen. Counsel of Marketing & Gov. Affairs(age: 52, pay: $630,220)
  • How many employees does Veradigm have?

    As Jul 2024, Veradigm employs 8,000 workers.

  • When Veradigm went public?

    Veradigm Inc. is publicly traded company for more then 26 years since IPO on 26 Jul 1999.

  • What is Veradigm's official website?

    The official website for Veradigm is veradigm.com.

  • Where are Veradigm's headquarters?

    Veradigm is headquartered at 222 Merchandise Mart Plaza, Chicago, IL.

  • How can i contact Veradigm?

    Veradigm's mailing address is 222 Merchandise Mart Plaza, Chicago, IL and company can be reached via phone at +800 3348534.

Veradigm company profile:

Veradigm Inc.

veradigm.com
Exchange:

OTC

Full time employees:

8,000

Industry:

Medical - Healthcare Information Services

Sector:

Healthcare

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as Veradigm Connect, Veradigm App Expo, and Diagnostic Ordering and Resulting Network; Channel Partner Program; and Veradigm ePrescribe Enterprise. In addition, the company offers solutions to health plans and payers, comprising risk adjustment solutions, such as Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics; quality management solutions, which include quality analytics and risk adjustment and quality management; data exchange+coding solutions, including eChart Courier, eChart Coder, and eChart Integration and Analytics; provider engagement and Veradigm Payer Insights; and Veradigm Payerpath solutions. Further, it provides solutions to biophama, including real world data solutions, such as real world and health data sets and cardiology and metabolic registries; real world evidence and Real World Evidence Analytics Platform; therapy focused solutions, such as cardiovascular, central nervous system, metabolic, and immunology data; and Digital Health Media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

222 Merchandise Mart Plaza
Chicago, IL 60654

CIK: 0001124804
ISIN: US01988P1084
CUSIP: 01988P108